Skip to main content
S&P 5007,718.94-1.11%DOW51,621.48-0.09%NASDAQ26,692.87-1.88%BTC$81,457.00-2.34%ETH$2,415.03-3.69%GOLD$4,164.50+1.38%OIL$94.45-0.67%
Smart Investors Daily
SID Premium
OP

NASDAQ · OPCH

Option Care Health, Inc.

Healthcare · Medical - Care Facilities

$31.12

Up+$0.02 (+0.06%)

Updated Oct 15, 2026, 4:19 AM

SID Score

5.8/10

Composite research score

Smart Money

62/100

Neutral

Market cap
5.42B
P/E ratio
25.69
Dividend yield
0.00%
52-week range
$18.01 – $36.80
Volume
4.93M
Avg. volume
2.15M

Price performance · OPCH

OPCH price history

1M range · 21 trading sessions · Daily adjusted prices

Prices through Oct 14, 2026

OPCH closed at $31.12 after 21 trading sessions, up 27.18% for the selected period.

Last close
$31.12
Period change
+27.18%
Period low
$22.49
Period high
$31.12
Daily close
View OHLC price history
OPCH OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 14, 2026$31.11$31.15$31.09$31.124.93M
Oct 13, 2026$31.13$31.17$31.09$31.105.01M
Oct 12, 2026$31.08$31.15$31.07$31.104.84M
Oct 9, 2026$31.05$31.11$31.0301$31.076.21M
Oct 8, 2026$31.05$31.085$31.01$31.059.66M
Oct 7, 2026$31.03$31.06$30.99$31.0119.35M
Oct 6, 2026$31.04$31.11$30.965$31.0065.08M
Oct 5, 2026$22.55$23.485$22.445$23.372.82M
Oct 2, 2026$22.59$22.93$22.41$22.641.26M
Oct 1, 2026$22.56$22.88$22.29$22.581.61M
Sep 30, 2026$22.83$22.83$22.34$22.491.57M
Sep 29, 2026$22.71$22.86$22.54$22.811.76M
Sep 28, 2026$23.07$23.50$22.85$22.901.89M
Sep 25, 2026$22.82$23.15$22.72$23.071.17M
Sep 24, 2026$23.31$23.52$22.83$22.941.46M
Sep 23, 2026$23.88$24.14$23.27$23.341.33M
Sep 22, 2026$24.04$24.48$23.88$23.902.14M
Sep 21, 2026$24.30$24.375$23.81$23.953.12M
Sep 18, 2026$24.48$24.48$23.745$24.305.68M
Sep 17, 2026$24.39$24.56$23.66$24.503.81M
Sep 16, 2026$23.59$24.88$23.225$24.473.72M

Latest OPCH news

The latest Smart Investors Daily articles mentioning OPCH.

Stock researchCompany · Overview

OPCH research

Overview

Company profile and research snapshot.

Company profile

Option Care Health Inc is the provider of home and alternate-site infusion services. It provides treatment for bleeding disorders, neurological disorders, heart failure, anti-infectives, and chronic inflammatory disorders among others.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
$37.00
Implied upside
—
Analysts
—
OPCH recent ratings
DateFirmRatingTarget
Oct 9, 2026UBSNeutral—
Oct 7, 2026CitizensMarket Perform—
Oct 7, 2026Barrington ResearchMarket Perform—
Oct 7, 2026JefferiesHold—
Oct 7, 2026William BlairMarket Perform—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 9, 2026

McKesson (MCK) Joins $5.8 Billion Option Care Health (OPCH) Acquisition. Is the Valuation Justified?

McKesson Corporation (NYSE:MCK) is expanding its specialty healthcare operations through a $5.8 billion acquisition (including debt) of Option Care Health, Inc. (NASDAQ:OPCH), partnering with private equity firm Clayton, Dubilier & Rice to take the infusion-services provider private. Announced on October 6, the transaction values Option Care at $32.05 per share, representing a 37% premium to […]

Yahoo · Oct 9, 2026

Option Care Health (OPCH) Faces Legal Review Of Its Proposed Takeover

Option Care Health (NasdaqGS:OPCH) faces shareholder investigations into its proposed sale to Clayton, Dubilier & Rice and McKesson Corporation. Several securities law firms announced probes into whether OPCH's board secured a fair price and process for investors. The legal reviews of the Clayton, Dubilier & Rice and McKesson deal only capture one slice of the Option Care Health story. Our analysis turns up 3 other big wins for Option Care Health as well. For a broader view on income...

Yahoo · Oct 9, 2026

Option Care Health (OPCH) Stock May Be Undervalued Despite The $5.8 Billion Buyout

Option Care Health shares have jumped into focus after a sharp move higher and a US$5.8b buyout agreement, which raises a straightforward question for investors who care about valuation. Does the current price around the deal level make sense when you line it up against the earnings the business is generating? The stock gained 37.5% over the past week, which puts fresh pressure on the question of whether that surge is matched by the company’s earnings power. The agreed US$32.05 per share...

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By